XFOR

X4 Pharmaceuticals, Inc

Healthcare · Biotechnology

$201.45 sample

-2.34 (-1.15%) 1D

Market cap

$358.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-10

Alerts

8

Price$201.45 +18.39% 3M daily closessample

210.83170.16

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider sell: 10% owner
Sep 28INSInsider sell: 10% owner
Sep 17INSInsider sell: Director
Sep 10SEC10-Q filed
Sep 07INSInsider sell: General Counsel
Sep 02INSInsider sell: 10% owner
Aug 27INSInsider sell: Chief Financial Officer
Aug 20SECDEF 14A filed

Sign up to see the real XFOR record →

Company facts

SEC EDGAR registration

Name: X4 Pharmaceuticals, Inc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +6sample, -100 to +100
Reporting currency: USD

Who is positioning in XFOR

sample

Insiders: 17 insider transactions over 90 days, net selling, $289.6M
Congress: 4 members traded over 90 days
Institutions · 13F: 35 funds hold $4.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$21.2B +20.6% y/y

Q4 2024Q3 2026

Inventory$12.7B +12.6% y/y

Q4 2024Q3 2026

Accounts receivable$9.7B +12.5% y/y

Q4 2024Q3 2026

Total debt$24.5B +12.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $111.2B +13.4% 3M
Sample peer B: $201.3B +5.0% 3M
Sample peer C: $284.5B +15.2% 3M
Sample peer D: $69.0B -0.2% 3M
Sample peer E: $132.7B +11.2% 3M